Cengiz CEYLAN, Gökhan MERİÇ, Aziz ATİK, Serdar SARGIN

Immunohistological effects of transforming growth factor-β via platelet-rich plasma on segmental bone defects: an animal study

Abstract: Bone healing is a different and unique process that results in complete bone tissue, rather than ending in scar formation. However, more significant bone defects may fail to regenerate and forms scary granulomatous tissue. This study aimed to investigate the efficacy of transforming growth factor-β (TGF - β) via platelet rich plasma (PRP) in rabbit tibia bones with segmental bone defects by radiological and immunohistological methods. Tibial segmental defects were performed to adult New Zealand rabbits (n = 10) on both legs. 0.5 mL of PRP was administered to the defect zone on one leg (PRP group), while the other leg was closed without PRP administration (control group). Following six weeks of observation samples were sent for immunohistological examination. According to Allen’s fracture healing score, the mean score was higher in the PRP group compared to the control group (3.2 vs. 1.3). Immunohistological evaluations revealed that in the control group, samples were mostly at the early stages of bone development, whereas in the PRP group, later stages of development were able to be observed (P < 0.05). PRP administration increases bone union, reduces healing time, and it may provide a more cost-effective treatment with fewer complications in segmental bone defects.Key words: Platelet-rich plasma, transforming growth factor, segmental bone defect, rabbit, tibia

PDF

___

1. Rawashdeh MA, Telfah H. Secondary alveolar bone grafting: the dilemma of donor site selection and morbidity. British Journal of Oral Maxillofacial Surgery 2008; 46 (8): 665- 670.
2. Jeong W, Kim YS, Roh TS, Kang EH, Jung BK, et al. The effect of combination therapy on critical-size bone defects using non-activated platelet-rich plasma and adipose-derived stem cells. Child’s Nervous System 2019: 1-7.
3. Marx RE. Platelet-rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery 2004; 62 (4): 48 - 496.
4. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. Journal of Oral Maxillofacial Surgery 2005; 63 (3): 362-369.
5. Rai B, Oest ME, Dupont KM, Ho KH, Teoh SH, et al. Combination of platelet-rich plasma with polycaprolactonetricalcium phosphate scaffolds for segmental bone defect repair. Journal of Biomedical Material Research Part A. 2007; 81 (4): 888-899.
6. Sarkar MR, Augat P, Shefelbine SJ, Schorlemmer S, Huber-Lang M, et al. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 2006; 27 (9): 1817-1823.
7. Kitoh H, Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H, et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases. Bone 2004; 35 (4): 892-898.
8. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Plateletrich plasma: where are we now and where are we going? Sports Health 2010; 2 (3): 203-210.
9. Chicharro-Alcantara D, Rubio-Zaragoza M, Damia-Gimenez E, Carrillo-Poveda JM, Cuervo-Serrato B, et al. Platelet Rich Plasma: New Insights for Cutaneous Wound Healing Management. Journal of Functional Biomaterials 2018; 9 (1).
10. Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiology 2013; 13: 47.
11. Comella K, Bell W. First-in-man intraglandular implantation of stromal vascular fraction and adipose-derived stem cells plus platelet-rich plasma in irradiation-induced gland damage: a case study. International Medical Case Reports Journal 2017; 10: 295-299.
12. Fu W, Li Q, Li J. Application of platelet-rich plasma in clinical orthopedics. Chinese Journal of Reparative and Reconstructive Surgery 2014; 28 (10): 1311-1316.
13. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. Journal of Oral Maxillofacial Surgery 2000; 58 (3): 297-300.
14. Hermeto LC, Rossi R, Padua SB, Pontes ER, Santana AE. Comparative study between fibrin glue and platelet rich plasma in dogs skin grafts. Acta Cirurgica Brasileria 2012; 27 (11): 789-794.
15. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. American Journal of Sports Medicine 2009; 37 (11): 2259-2272.
16. Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet Rich Plasma: a short overview of certain bioactive components. Open Medical (Wars) 2016; 11 (1): 242-247.
17. Murphy MK, Huey DJ, Hu JC, Athanasiou KA. TGF-beta1, GDF-5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells. Stem Cells 2015; 33 (3): 762-773.
18. Mehlhorn AT, Niemeyer P, Kaschte K, Muller L, Finkenzeller G, et al. Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells. Cell Proliferation 2007; 40 (6): 809-823.
19. Ramezanifard R, Kabiri M, Hanaee Ahvaz H. Effects of platelet rich plasma and chondrocyte co-culture on MSC chondrogenesis, hypertrophy and pathological responses. Experimental and Clinical Sciences, International Online Journal for Advances in Sciences 2017; 16: 1031-1045.
20. Liou JJ, Rothrauff BB, Alexander PG, Tuan RS. Effect of plateletrich plasma on chondrogenic differentiation of adipose- and bone marrow-derived mesenchymal stem cells. Tissue English Part A. 2018; 24 (19-20) : 1432-1443.
21. Wu MY, Hill CS. Tgf-beta superfamily signaling in embryonic development and homeostasis. Developmental Cell 2009; 16 (3): 329-343.
22. Ghosh D, McGrail DJ, Dawson MR. TGF-beta1 Pretreatment improves the function of mesenchymal stem cells in the wound bed. Frontiers in Cell and Developmental Biology. 2017; 5: 28.
23. Somoza RA, Welter JF, Correa D, Caplan AI. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Engineering Part B Reviews 2014; 20 (6): 596-608.
24. Malhotra A, Pelletier MH, Yu Y, Walsh WR. Can plateletrich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Archives of Orthopedics and Trauma Surgery 2013 ; 133 (2) : 153 - 165.
25. Kumar GS. Orban’s Oral Histology and Embryology. 14 ed: Elsevier (A Divisionof Reed Elsevier India Pvt. Limited); 2015.
26. Rahman MS, Akhtar N, Jamil HM, Banik RS, Asaduzzaman SM. TGF-beta/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Research. 2015; 3: 15005.
27. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. The Journal of Biochemistry 2010; 147 (1): 35-51.
28. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. Journal of Cutaneous and Aesthetic Surgery. 2014; 7 (4): 189-197.
29. Nagata MJ, Messora MR, Furlaneto FA, Fucini SE, Bosco AF, et al. Effectiveness of two methods for preparation of autologous platelet-rich plasma: an experimental study in rabbits. European Journal of Dentistry 2010; 4 (4): 395-402.
30. Singhal P, Agarwal S, Dhot PS, Sayal SK. Efficacy of plateletrich plasma in treatment of androgenic alopecia. Asian Journal of Transfusion Science 2015; 9 (2): 159-162.
31. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthopaedica Scandinavica 1980; 51 (4): 595-600.
32. Estai MA, Soelaiman IN, Shuid AN, Das S, Ali AM, et al. Histological changes in the fracture callus following the administration of water extract of piper sarmentosum (daun kadok) in estrogen-deficient rats. Iranian Journal of Medical Sciences 2011; 36 (4): 281-288.
33. Swennen GR, Schutyser F, Mueller MC, Kramer FJ, Eulzer C, et al. Effect of platelet-rich-plasma on cranial distraction osteogenesis in sheep: preliminary clinical and radiographic results. International Journal of Oral Maxillofacial Surgery 2005; 34 (3): 294-304.
34. Ali AM, El-Alfy B, Amin M, Nematalla M, El-Shafaey el SA. Can platelet-rich plasma shorten the consolidation phase of distraction osteogenesis? An experimental study. European Journal of Orthopedic Surgery and Traumatology 2015; 25 (3): 543-548.
35. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. The Journal of Cell Biology 1990; 110 (6): 2195-2207.
36. Wildemann B, Schmidmaier G, Ordel S, Stange R, Haas NP, et al. Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers, PCNA and BrdU. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2003; 65 (1): 150-156.
37. Schmidmaier G, Wildemann B, Heeger J, Gabelein T, Flyvbjerg A, et al. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factorbeta1. Bone 2002; 31 (1): 165-172.
38. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 1998; 85 (6): 638-646.
39. Farhadieh RD, Dickinson R, Yu Y, Gianoutsos MP, Walsh WR. The role of transforming growth factor-beta, insulin-like growth factor I, and basic fibroblast growth factor in distraction osteogenesis of the mandible. Journal of Craniofacial Surgery 1999; 10 (1): 80-86.
40. Liu Z, Luyten FP, Lammens J, Dequeker J. Molecular signaling in bone fracture healing and distraction osteogenesis. Histology and Histopathology 1999; 14 (2): 587-595.
41. Steinbrech DS, Mehrara BJ, Rowe NM, Dudziak ME, Luchs JS, et al. Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats. Plastic and Reconstructive Surgery 2000; 105 (6): 2028-2038.
42. Zimmermann G, Henle P, Küsswetter M, Moghaddam A, Wentzensen A, et al. TGF-β1 as a marker of delayed fracture healing. Bone 2005; 36 (5): 779-785.
43. Kaiser G, Thomas A, Köttstorfer J, Kecht M, Sarahrudi K. Is the expression of transforming growth factor-Beta1 after fracture of long bones solely influenced by the healing process? International Orthopaedics 2012; 36 (10): 2173-2179.
44. Sarahrudi K, Thomas A, Mousavi M, Kaiser G, Kottstorfer J, et al. Elevated transforming growth factor-beta 1 (TGF-beta1) levels in human fracture healing. Injury 2011; 42 (8): 833-837.
45. Lind M, Schumacker B, Soballe K, Keller J, Melsen F, et al. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthopaedica Scandinavica 1993; 64 (5): 553-556.
46. Srouji S, Blumenfeld I, Rachmiel A, Livne E. Bone defect repair in rat tibia by TGF-beta1 and IGF-1 released from hydrogel scaffold. Cell and Tissue Banking 2004; 5 (4): 223- 230.
47. Kanthan SR, Kavitha G, Addi S, Choon DS, Kamarul T. Platelet-rich plasma (PRP) enhances bone healing in nonunited critical-sized defects: a preliminary study involving rabbit models. Injury 2011; 42 (8): 782-789.